Neurology & Neurotherapeutics - NE Outside Agreements

Research Output 1984 2019

Filter
Editorial
2019
1 Citation (Scopus)

Neurofilament light chain: An important step toward a disease biomarker in multiple sclerosis

Berger, T. & Stuve, O., Mar 5 2019, In : Neurology. 92, 10, p. 451-452 2 p.

Research output: Contribution to journalEditorial

Intermediate Filaments
Multiple Sclerosis
Biomarkers
Light
2016
1 Citation (Scopus)

MTORC1 inhibition for epilepsy in TSC

Sparagana, S. P., Sep 6 2016, In : Neurology. 87, 10, p. 974-975 2 p.

Research output: Contribution to journalEditorial

Epilepsy
Multiple Sclerosis
B-Lymphocytes
laquinimod
2 Citations (Scopus)
Cerebral Palsy
Mexico
Neurodevelopmental Disorders
2014
1 Citation (Scopus)

The genetics of natalizumab hypersensitivity: One learns to itch where one can scratch

Stüve, O. & Hemmer, B., Dec 1 2014, In : Neurology: Neuroimmunology and NeuroInflammation. 1, 4, e52.

Research output: Contribution to journalEditorial

Hypersensitivity
Natalizumab
2008
2 Citations (Scopus)

Natalizumab: Increased vigilance is required in treating patients with multiple sclerosis

Racke, M. K. & Stüve, O., 2008, In : Therapeutic Advances in Neurological Disorders. 1, 3, p. 155-156 2 p.

Research output: Contribution to journalEditorial

Multiple Sclerosis
Natalizumab